We performed a 5-question survey of 20 infectious disease (ID) specialists in the U.S. to gauge current prescribing practices for community-acquired pneumonia (CAP) and gauge interest in new drugs/new drug candidates. Topics covered in this survey include:
- Current usage of antibiotics for CAP, grouped by antibiotic class
- Bacterial pathogens of greatest current concern in CAP
- Prescribing preferences following failure of 1st-line empiric CAP therapy
- Potential prescribing levels for CAP drugs with greater potency than existing (generic) drugs but higher price

Appendix : Development status for Selected Antibiotics